Pituitary disease is associated with increased mortality predominantly due to vascular
disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor …

Objective: The objective is to provide guidelines for the evaluation and treatment of adults
with GH deficiency (GHD). Participants: The chair of the Task Force was selected by the …

Objective: The aim was to update The Endocrine Society Clinical Practice Guideline on
Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published …

Summary Background GH and IGF‐I affect cardiac structure and performance. In the general
population, low IGF‐I has been associated with higher prevalence of ischaemic heart …

The syndrome of adult GH deficiency and the effects of GH replacement therapy provide a
useful model with which to study the effects of the GH/IGF-I axis on exercise physiology …

Background—Growth hormone (GH) treatment may improve morphological and functional
cardiac parameters in adults with GH deficiency (GHD). However, clinical trials reported to …

Objective The aim of the present study was to clarify the relationship between GH deficiency
(GHD) and some cardiovascular risk factors and to analyse the effect of GH replacement …

The clinical conditions associated with GH excess and GH deficiency (GHD) are known to
be associated with an increased risk for the cardiovascular morbidity and mortality …

GH replacement therapy has been shown to improve abnormalities in body composition,
bone mineral density (BMD), lipid profile, and other changes resulting from GH deficiency …

Nutritional markers, such as lean body mass (LBM) and serum albumin, predict outcome in
dialysis patients, in whom protein-energy malnutrition is associated with increased morbidity …